• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products

  • An evaluation of efficacy and safety of corresponding doses of Pulmicort Turbuhaler and Pulmicort Respules in Japanese asthmatic adult patients (open, multicenter, phase III study)

Disease
asthma
Drug Name
Pulmicort
Generic Name
budesonide
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
III
Start Date
Feb 19, 2009
Study Name
D5259C00001
Study Id
D5259C00001
ClinicalTrials.gov ID
NCT00855959
Recruiting Status
Open
Protocol Status
Not Available
Report
Jan 8, 2010
  • D5259C00001.pdf (569 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013